is retatrutide on the market yet Houston for Weight Loss and Weight Management Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

The Gallup poll also found that the percentage of Americans with obesity decreased from 39.9% in 2022 to 37.0% in 2025, a three-percentage-point decrease that represents 7.6 million people

More than just diabetes Since their introduction, GLP-1 RAs have revealed a surprising range of biological effects extending well beyond glucose control (Fig 1)

Get Free Sample Report This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts

Each serving delivers 1,957 mg of three synergistic prebiotic fibers: PreticX Xylooligosaccharides (XOS) A patented prebiotic clinically shown to selectively nourish Bifidobacterium and other beneficial bacteria

The body resists continued rapid loss through metabolic adaptation, requiring either patience or intervention

Lyophilized retatrutide stored at 20C retains 95%+ potency for 1218 months